4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0000899243-21-033505
Director bought 50,000 shares at an average $2.76 ($138,188)
From the SEC's structured data for this filing
Trades in this filing
ARMISTICE CAPITAL, LLC · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-16 | Purchase : show line 1 in the form | +30,000 | $2.75 | $82,638 | 39,280,000 | I |
| 2021-08-18 | Purchase : show line 2 in the form | +20,000 | $2.78 | $55,550 | 39,300,000 | I |
| Open-market purchases · 50,000 sh · avg $2.76 · $138,188 | ||||||
Loading xslF345X03/doc4.xml…